Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.21−0.08 (-1.27%)
Close on Nov 17, 2026Market cap $279.58MP/E –Yield –
Agenus cash
Cash and short-term investments held at the end of each period.
Agenus's cash was $18.74M at Jun 30, 2026. For fiscal 2025 it was $3.00M, down 92.6% from the year before. Over ten years it grew -33.3% a year on average. The highest annual figure on record is $306.90M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00M | -92.6% |
| FY2024 | Dec 31, 2024 | $40.40M | -46.9% |
| FY2023 | Dec 31, 2023 | $76.10M | -60.7% |
| FY2022 | Dec 31, 2022 | $193.40M | -37.0% |
| FY2021 | Dec 31, 2021 | $306.90M | +207.3% |
| FY2020 | Dec 31, 2020 | $99.87M | +61.6% |
| FY2019 | Dec 31, 2019 | $61.81M | +16.4% |
| FY2018 | Dec 31, 2018 | $53.10M | -11.8% |
| FY2017 | Dec 31, 2017 | $60.20M | -21.2% |
| FY2016 | Dec 31, 2016 | $76.40M | -55.5% |
| FY2015 | Dec 31, 2015 | $171.70M | +326.9% |
| FY2014 | Dec 31, 2014 | $40.22M | +47.1% |
| FY2013 | Dec 31, 2013 | $27.35M | +27.4% |
| FY2012 | Dec 31, 2012 | $21.47M | +99.7% |
| FY2011 | Dec 31, 2011 | $10.75M | -45.7% |
| FY2010 | Dec 31, 2010 | $19.78M | -1.4% |
| FY2009 | Dec 31, 2009 | $20.07M | -18.0% |
| FY2008 | Dec 31, 2008 | $24.47M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.74M | +97.2% |
| Q1 FY2026 | Mar 31, 2026 | $35.00M | +89.2% |
| Q4 FY2025 | Dec 31, 2025 | $3.00M | -92.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.50M | -92.2% |
| Q2 FY2025 | Jun 30, 2025 | $9.50M | -89.9% |
| Q1 FY2025 | Mar 31, 2025 | $18.50M | -65.0% |
| Q4 FY2024 | Dec 31, 2024 | $40.40M | -46.9% |
| Q3 FY2024 | Sep 30, 2024 | $44.80M | -57.9% |
| Q2 FY2024 | Jun 30, 2024 | $93.70M | -40.7% |
| Q1 FY2024 | Mar 31, 2024 | $52.90M | -72.0% |
| Q4 FY2023 | Dec 31, 2023 | $76.10M | -60.7% |
| Q3 FY2023 | Sep 30, 2023 | $106.30M | -51.3% |
| Q2 FY2023 | Jun 30, 2023 | $157.90M | -33.7% |
| Q1 FY2023 | Mar 31, 2023 | $189.20M | -28.0% |
| Q4 FY2022 | Dec 31, 2022 | $193.40M | -37.0% |
| Q3 FY2022 | Sep 30, 2022 | $218.20M | -16.6% |
| Q2 FY2022 | Jun 30, 2022 | $238.30M | +224.0% |
| Q1 FY2022 | Mar 31, 2022 | $262.70M | +120.1% |
| Q4 FY2021 | Dec 31, 2021 | $306.90M | +207.3% |
| Q3 FY2021 | Sep 30, 2021 | $261.50M | +129.1% |
| Q2 FY2021 | Jun 30, 2021 | $73.54M | -7.1% |
| Q1 FY2021 | Mar 31, 2021 | $119.37M | +29.3% |
| Q4 FY2020 | Dec 31, 2020 | $99.87M | +61.6% |
| Q3 FY2020 | Sep 30, 2020 | $114.14M | +22.4% |
| Q2 FY2020 | Jun 30, 2020 | $79.17M | -35.0% |
| Q1 FY2020 | Mar 31, 2020 | $92.28M | -41.7% |
| Q4 FY2019 | Dec 31, 2019 | $61.81M | +16.4% |
| Q3 FY2019 | Sep 30, 2019 | $93.27M | +102.0% |
| Q2 FY2019 | Jun 30, 2019 | $121.72M | +182.0% |
| Q1 FY2019 | Mar 31, 2019 | $158.31M | +202.4% |
| Q4 FY2018 | Dec 31, 2018 | $53.10M | -11.8% |
| Q3 FY2018 | Sep 30, 2018 | $46.17M | -34.1% |
| Q2 FY2018 | Jun 30, 2018 | $43.16M | -55.4% |
| Q1 FY2018 | Mar 31, 2018 | $52.35M | -57.7% |
| Q4 FY2017 | Dec 31, 2017 | $60.20M | -21.2% |
| Q3 FY2017 | Sep 30, 2017 | $70.10M | -26.5% |
| Q2 FY2017 | Jun 30, 2017 | $96.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $123.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $76.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $95.40M | – |
See a number that looks wrong?